Brenus Pharma vs Juno Therapeutics

Brenus Pharma vs Juno Therapeutics, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Brenus Pharma is on 48/100 and Juno Therapeutics on 66/100.

Brenus Pharma logo
Brenus PharmaClinical-stage immunotherapy company developing novel treatments for cancer.
Try Brenus Pharma
Juno TherapeuticsBiotechnology company focused on developing cancer immunotherapies.

Where each one leads

Brenus Pharma

Leads on none of the measures we hold for both companies.

Juno Therapeutics

  • our overall score: 66/100 against 48/100
  • funding raised: $317M against $12.6M

At a glance

MeasureBrenus PharmaJuno Therapeutics
What it isClinical-stage immunotherapy company developing novel treatments for cancer.Biotechnology company focused on developing cancer immunotherapies.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Pharmaceuticals, Cancer Immunotherapy, Cart
Sells toBusiness modelB2BB2B
OfferingPlatformServices
FoundedNot published2013
HeadquartersLyon, FranceSeattle, United States
StatusActiveActive

Size, funding and growth

MeasureBrenus PharmaJuno Therapeutics
Employees29Not published
Total funding$12.6M$317M
Latest roundSeries ASeries B
LinkedIn followers6,500Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBrenus PharmaJuno Therapeutics
StartupHub scoreOur 0-100 rating48/10066/100
Traction50/10040/100
TeamNot published90/100
CommunityNot published15/100
Search visibility31/10015/100
Quality62/10087/100
Agent readinessHow well an AI agent can read and act on the siteF (36/100)Not published

Brenus Pharma vs Juno Therapeutics: common questions

Which is better, Brenus Pharma or Juno Therapeutics?

On our 0-100 score Juno Therapeutics rates higher (66/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.

How do Brenus Pharma and Juno Therapeutics compare on the numbers?

Juno Therapeutics leads on our overall score (66/100 against 48/100), funding raised ($317M against $12.6M).

Read the full Brenus Pharma review and pricing or the Juno Therapeutics review and pricing. You can also browse other Brenus Pharma alternatives we track.